Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
8.53
+0.63 (7.97%)
At close: Mar 4, 2026, 4:00 PM EST
8.60
+0.07 (0.82%)
Pre-market: Mar 5, 2026, 4:27 AM EST
Cybin Market Cap
Cybin has a market cap or net worth of $426.81 million as of March 5, 2026. Its market cap has increased by 112.90% in one year.
Market Cap
426.81M
Enterprise Value
231.68M
1-Year Change
112.90%
Ranking
Category
Stock Price
$8.53
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $426.81M, an increase of 368.52%. That is a compound annual growth rate of 33.76%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 392.90M |
| Armata Pharmaceuticals | 391.74M |
| Candel Therapeutics | 384.55M |
| Greenwich LifeSciences | 384.05M |
| NovaBridge Biosciences | 378.15M |
| Aura Biosciences | 374.03M |
| Benitec Biopharma | 373.38M |
| Monopar Therapeutics | 366.24M |